Neuphoria Therapeutics (BNOXN) Q2 2023 Earnings Report
MX:BNOXN Q2 2023 EPS Results
- Actual EPS
- -MXN 308.08
- Consensus EPS
- -MXN 139.15
- Beat/Miss
- Missed by -MXN 168.92
- One Year Ago EPS
- -MXN 106.85
MX:BNOXN Q2 2023 Revenue Results
- Actual Revenue
- MXN 0
- Expected Revenue
- MXN 4.89M
- Beat/Miss
- Missed by -MXN 4.89M
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 02/23/2023
- Time
- Before Open
- Conference Call
- Thursday, February 23, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:BNOXN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Sep 29, 2025 | 2025 (Q4) | -36.26-45.92 | -509.96 | 91.00% (+464.04) | |
| Feb 20, 2025 | 2025 (Q2) | ―- | ― | ― | |
| Aug 21, 2024 | 2024 (Q4) | -16.55-16.55 | -18.44 | 10.23% (+1.89) | |
| Feb 22, 2024 | 2024 (Q2) | ―-18.45 | -25.67 | 28.10% (+7.21) | |
| Aug 23, 2023 | 2023 (Q4) | -19.55- | -20.13 | ― | |
| Feb 23, 2023 | 2023 (Q2) | -139.15-308.08 | -106.85 | -188.32% (-201.22) | |
| Aug 25, 2022 | 2022 (Q4) | -20364.91-241.64 | -0.16 | -153677.78% (-241.48) | |
| Feb 22, 2022 | 2022 (Q2) | -214.67-106.85 | 0 | ― | |
| Aug 25, 2021 | 2021 (Q4) | 0.00-0.16 | 0 | ― | |
| Feb 26, 2021 | 2021 (Q2) | 0.000.00 | -19.42 | 100.00% (+19.42) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
